Best Chinese Stocks Worth Watching - October 12th

Key Points

• Diageo, UP Fintech, and Regencell Bioscience are highlighted as the top Chinese stocks to watch due to their high trading volume and exposure to China's economic growth.
• UP Fintech specializes in online brokerage services targeting Chinese investors, offering a platform for trading various financial instruments.
• Regencell Bioscience focuses on Traditional Chinese Medicine and is engaged in the research and commercialization of treatments for neurocognitive disorders.

Diageo, UP Fintech, and Regencell Bioscience are the three Chinese stocks to watch today, according to MarketBeat's stock screener tool. Chinese stocks are equity securities representing ownership in companies that are incorporated in or derive most of their revenue from Mainland China. They trade primarily on domestic bourses such as the Shanghai and Shenzhen Stock Exchanges, or via H-shares, Red-chips in Hong Kong and American Depositary Receipts (ADRs) in the United States. Investors use them to gain exposure to China’s economic growth, while weighing risks like regulatory shifts, currency fluctuations and geopolitical tensions. These companies had the highest dollar trading volume of any Chinese stocks within the last several days.

Diageo (DEO)

Diageo plc, together with its subsidiaries, engages in the production, marketing, and sale of alcoholic beverages. The company offers scotch, gin, vodka, rum, raki, liqueur, wine, tequila, Chinese white spirits, cachaça, and brandy, as well as beer, including cider and flavored malt beverages. It also provides Chinese, Canadian, Irish, American, and Indian-Made Foreign Liquor whiskies, as well as flavored malt beverages, ready to drink, and non-alcoholic products.

Read Our Latest Research Report on DEO

UP Fintech (TIGR)

UP Fintech Holding Limited provides online brokerage services focusing on Chinese investors. The company has developed a brokerage platform, which allows investor to trade stocks, options, warrants, and other financial instruments that can be accessed through its APP and website. It offers brokerage and value-added services, including investor education, community engagement, and IR platform services.

Read Our Latest Research Report on TIGR

Regencell Bioscience (RGC)

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder.

Read Our Latest Research Report on RGC